協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/09/03 | 3,283 | 3,311 | 3,268 | 3,302 | +19 | +0.6% | 615,000 |
| 2024/09/02 | 3,298 | 3,314 | 3,255 | 3,283 | -42 | -1.3% | 681,400 |
| 2024/08/30 | 3,308 | 3,325 | 3,269 | 3,325 | +25 | +0.8% | 2,780,700 |
| 2024/08/29 | 3,320 | 3,350 | 3,293 | 3,300 | -10 | -0.3% | 935,000 |
| 2024/08/28 | 3,300 | 3,316 | 3,283 | 3,310 | +10 | +0.3% | 961,200 |
| 2024/08/27 | 3,272 | 3,300 | 3,245 | 3,300 | +46 | +1.4% | 822,000 |
| 2024/08/26 | 3,221 | 3,259 | 3,163 | 3,254 | -5 | -0.2% | 1,012,900 |
| 2024/08/23 | 3,175 | 3,264 | 3,175 | 3,259 | +101 | +3.2% | 1,247,300 |
| 2024/08/22 | 3,100 | 3,169 | 3,093 | 3,158 | +46 | +1.5% | 1,100,100 |
| 2024/08/21 | 3,123 | 3,143 | 3,104 | 3,112 | -28 | -0.9% | 721,600 |
| 2024/08/20 | 3,128 | 3,159 | 3,109 | 3,140 | +52 | +1.7% | 850,000 |
| 2024/08/19 | 3,125 | 3,136 | 3,068 | 3,088 | -72 | -2.3% | 940,400 |
| 2024/08/16 | 3,094 | 3,164 | 3,090 | 3,160 | +109 | +3.6% | 1,105,000 |
| 2024/08/15 | 3,047 | 3,086 | 3,046 | 3,051 | -28 | -0.9% | 841,600 |
| 2024/08/14 | 3,079 | 3,092 | 3,015 | 3,079 | +38 | +1.2% | 1,083,600 |
| 2024/08/13 | 3,014 | 3,065 | 2,983.5 | 3,041 | +74.5 | +2.5% | 1,484,100 |
| 2024/08/09 | 3,002 | 3,023 | 2,905.5 | 2,966.5 | +5 | +0.2% | 1,389,100 |
| 2024/08/08 | 2,962 | 3,021 | 2,934.5 | 2,961.5 | +9.5 | +0.3% | 1,228,900 |
| 2024/08/07 | 2,974 | 3,044 | 2,874 | 2,952 | -63 | -2.1% | 1,566,000 |
| 2024/08/06 | 2,909.5 | 3,059 | 2,871.5 | 3,015 | +197.5 | +7% | 2,196,100 |
| 2024/08/05 | 2,987 | 3,044 | 2,797 | 2,817.5 | -239.5 | -7.8% | 1,977,900 |
| 2024/08/02 | 3,083 | 3,177 | 3,045 | 3,057 | -60 | -1.9% | 1,690,000 |
| 2024/08/01 | 3,154 | 3,178 | 3,082 | 3,117 | -62 | -2% | 948,500 |
| 2024/07/31 | 3,127 | 3,196 | 3,120 | 3,179 | +14 | +0.4% | 798,500 |
| 2024/07/30 | 3,183 | 3,190 | 3,150 | 3,165 | -9 | -0.3% | 609,500 |
| 2024/07/29 | 3,155 | 3,206 | 3,147 | 3,174 | +19 | +0.6% | 730,900 |
| 2024/07/26 | 3,150 | 3,185 | 3,150 | 3,155 | +39 | +1.3% | 852,500 |
| 2024/07/25 | 3,110 | 3,153 | 3,100 | 3,116 | -33 | -1% | 954,400 |
| 2024/07/24 | 3,159 | 3,197 | 3,142 | 3,149 | -49 | -1.5% | 699,500 |
| 2024/07/23 | 3,165 | 3,206 | 3,159 | 3,198 | +27 | +0.9% | 683,200 |
| 2024/07/22 | 3,196 | 3,206 | 3,153 | 3,171 | +1 | ±0% | 700,700 |
| 2024/07/19 | 3,126 | 3,180 | 3,106 | 3,170 | +5 | +0.2% | 658,100 |
| 2024/07/18 | 3,170 | 3,195 | 3,152 | 3,165 | -13 | -0.4% | 833,800 |
| 2024/07/17 | 3,177 | 3,196 | 3,148 | 3,178 | +78 | +2.5% | 1,078,500 |
| 2024/07/16 | 3,122 | 3,140 | 3,079 | 3,100 | -7 | -0.2% | 649,400 |
| 2024/07/12 | 3,100 | 3,128 | 3,043 | 3,107 | +6 | +0.2% | 1,420,700 |
| 2024/07/11 | 3,110 | 3,129 | 3,089 | 3,101 | -1 | ±0% | 1,113,500 |
| 2024/07/10 | 3,070 | 3,118 | 3,070 | 3,102 | +18 | +0.6% | 1,250,100 |
| 2024/07/09 | 2,958.5 | 3,091 | 2,953 | 3,084 | +155.5 | +5.3% | 1,951,500 |
| 2024/07/08 | 2,904 | 2,933 | 2,896 | 2,928.5 | +18.5 | +0.6% | 817,400 |
| 2024/07/05 | 2,929.5 | 2,937.5 | 2,889 | 2,910 | -27.5 | -0.9% | 1,103,500 |
| 2024/07/04 | 2,845 | 2,938.5 | 2,836 | 2,937.5 | +173 | +6.3% | 1,824,700 |
| 2024/07/03 | 2,775.5 | 2,786.5 | 2,752 | 2,764.5 | -6 | -0.2% | 1,025,100 |
| 2024/07/02 | 2,755 | 2,773.5 | 2,712.5 | 2,770.5 | -1.5 | -0.1% | 1,241,100 |
| 2024/07/01 | 2,750.5 | 2,777 | 2,748 | 2,772 | +24.5 | +0.9% | 913,800 |
| 2024/06/28 | 2,718.5 | 2,749 | 2,718 | 2,747.5 | +22.5 | +0.8% | 819,100 |
| 2024/06/27 | 2,695.5 | 2,739.5 | 2,681 | 2,725 | -48.5 | -1.7% | 912,400 |
| 2024/06/26 | 2,748 | 2,780.5 | 2,734.5 | 2,773.5 | +26 | +0.9% | 881,500 |
| 2024/06/25 | 2,705.5 | 2,750 | 2,705.5 | 2,747.5 | +49 | +1.8% | 708,100 |
| 2024/06/24 | 2,708 | 2,717 | 2,691.5 | 2,698.5 | +5 | +0.2% | 730,100 |
201～
250
件表示中 / 3732件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 243,700円 | -3.5% | -11.3% | 2.46% | 22.38倍 | 1.52倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 139,100円 | +0.9% | +380.2% | 5.61% | 19.16倍 | 1.68倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 254,800円 | +20.9% | +10.6% | 2.59% | 12.04倍 | 1.62倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 407,300円 | +0.1% | -3.4% | 3.93% | 27.69倍 | 1.39倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 153,900円 | +0.6% | +43.3% | 5.20% | 10.79倍 | 0.94倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
